Archives of General Internal Medicine

Reach Us +1 (202) 780-3397

Mini Review - Archives of General Internal Medicine (2024) Volume 8, Issue 3

The Gut Microbiota and Immune System Crosstalk: Implications for Health and Disease

Huan Cangtang *

School of Pharmacy, Jiangsu University, China

*Corresponding Author:
Huan Cangtang
School of Pharmacy, Jiangsu University, China
E-mail: canghuantang@ujs.edu.cn

Received: 28-May-2024, Manuscript No. AAAGIM-24-136830; Editor assigned: 30-May-2024, PreQC No. AAAGIM-24-136830 (PQ); Reviewed: 13-Jun-2024, QC No. AAAGIM-24-136830; Revised: 17-Jun-2024, Manuscript No. AAAGIM-24-136830(R); Published: 24-Jun-2024, DOI:10.35841/aaagim-8.3.234

Citation: : Cangtang H. The Gut microbiota and immune system crosstalk: Implications for health and disease. Arch Gen Intern Med. 2024;8(3):234.

Visit for more related articles at Archives of General Internal Medicine

Introduction

The human body is home to trillions of microorganisms, collectively known as the microbiota, which play crucial roles in maintaining health. Among these, the gut microbiota has garnered significant attention for its intricate interactions with the immune system. This crosstalk between gut microbes and immune cells is essential for maintaining homeostasis, defending against pathogens, and influencing overall health. Disruptions in this delicate balance can lead to a variety of diseases, highlighting the importance of understanding this dynamic relationship [1, 2].

The gut microbiota is a complex community of bacteria, viruses, fungi, and other microorganisms residing primarily in the intestines. It is dominated by two bacterial phyla: Firmicutes and Bacteroidetes. The composition of the gut microbiota is influenced by factors such as diet, genetics, age, and environment. These microorganisms perform various functions critical for health. They aid in the digestion of complex carbohydrates, synthesize vitamins (e.g., vitamin K and B vitamins), and produce Short-Chain Fatty Acids (SCFAs) like butyrate, propionate, and acetate, which are vital for colon health. Moreover, the gut microbiota plays a crucial role in the development and function of the immune system [3, 4].

The gut microbiota is essential for the maturation of the immune system. From birth, microbial exposure begins to shape the neonatal immune system. Germ-free animal studies have shown that the absence of microbiota leads to underdeveloped immune systems, characterized by reduced Gut-Associated Lymphoid Tissue (GALT), fewer Peyer’s patches, and diminished production of immunoglobulins. Microbial antigens and metabolites interact with Pattern Recognition Receptors (PRRs) such as Toll-Like Receptors (TLRs) on immune cells, stimulating the immune system and promoting its maturation. This interaction leads to the production of cytokines and other signaling molecules that help in the differentiation of immune cells and the establishment of immune tolerance. SCFAs produced by gut bacteria influence the immune response. Butyrate, for instance, has anti-inflammatory properties and promotes the differentiation of regulatory T cells (Tregs), which are crucial for maintaining immune tolerance [5, 6].

Dysbiosis, or an imbalance in the gut microbiota, is associated with conditions like Crohn’s disease and ulcerative colitis. These conditions are characterized by chronic inflammation of the gut, partly due to inappropriate immune responses to commensal bacteria. Restoring microbial balance through probiotics, prebiotics, or Fecal Microbiota Transplantation (FMT) has shown promise in managing IBD. Early-life microbial exposure is crucial for developing immune tolerance. A lack of microbial diversity in infancy has been linked to an increased risk of allergic diseases and asthma. The "hygiene hypothesis" suggests that reduced exposure to microbes in modern, sanitized environments may contribute to the rise in allergic diseases [7, 8].

The gut microbiota influences metabolic processes and energy balance. Dysbiosis is associated with obesity, insulin resistance, and type 2 diabetes. SCFAs, produced by gut bacteria, play a role in regulating glucose and lipid metabolism. Modulating the gut microbiota through diet or probiotics could potentially aid in managing metabolic disorders. The gut microbiota influences the development of autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and type 1 diabetes. Dysbiosis can lead to a breakdown in immune tolerance and the production of autoantibodies. Restoring microbial balance might help in preventing or managing autoimmune diseases. The gut microbiota can influence cancer development and progression. Certain bacteria can produce carcinogenic compounds, while others can enhance the efficacy of cancer immunotherapies. For example, the presence of specific gut bacteria has been shown to improve the response to checkpoint inhibitors in cancer treatment [9, 10].

Conclusion

The crosstalk between the gut microbiota and the immune system is a critical aspect of human health. This dynamic relationship influences the development and function of the immune system, protects against pathogens, and maintains overall health. Disruptions in this balance can lead to a wide range of diseases, from inflammatory and autoimmune conditions to metabolic and mental health disorders. Understanding and harnessing this crosstalk holds promise for novel therapeutic approaches aimed at restoring and maintaining health.

References

  1. Bairamian D, Sha S, Rolhion N, et al. Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease. Mol Neurodegener. 2022;17(1):19.

    2. Indexed at, Google Scholar, Cross Ref

  2. Tavakoli PP, Vollmer-Conna U, Hadzi-Pavlovic D, et al. A review of inflammatory bowel disease: a model of microbial, immune and neuropsychological integration. Public Health Rev. 2021;42:1603990.

    3. Indexed at, Google Scholar, Cross Ref

  3. Papotto PH, Yilmaz B, Silva-Santos B. Crosstalk between γδ T cells and the microbiota. Nat Microbiol. 2021;6(9):1110-7.

    4. Indexed at, Google Scholar, Cross Ref

  4. Bajpai P, Darra A, Agrawal A. Microbe-mitochondrion crosstalk and health: An emerging paradigm. Mitochondrion. 2018;39:20-5.

    5. Indexed at, Google Scholar, Cross Ref

  5. Maffei S, Forini F, Canale P, et al. Gut microbiota and sex hormones: crosstalking players in cardiometabolic and cardiovascular disease. Int J Mol Sci. 2022;23(13):7154.

    6. Indexed at, Google Scholar, Cross Ref

  6. Liu Y, Alookaran JJ, Rhoads JM. Probiotics in autoimmune and inflammatory disorders. Nutrients. 2018;10(10):1537.

    7. Indexed at, Google Scholar, Cross Ref

  7. Caputi V, Popov J, Giron MC, et al. Gut microbiota as a mediator of host neuro-immune interactions: implications in neuroinflammatory disorders. Mod Trends Psychiatry. 2021;32:40-57.

    8. Indexed at, Google Scholar, Cross Ref

  8. Brial F, Le Lay A, Dumas ME, et al. Implication of gut microbiota metabolites in cardiovascular and metabolic diseases. Cell Mol Life Sci. 2018;75:3977-90.

    9. Indexed at, Google Scholar, Cross Ref

  9. Van Belkum M, Mendoza Alvarez L, Neu J. Preterm neonatal immunology at the intestinal interface. Cell Mol Life Sci. 2020;77:1209-27.

    10. Indexed at, Google Scholar, Cross Ref

  10. El Aidy S, Dinan TG, Cryan JF. Gut microbiota: the conductor in the orchestra of immune– neuroendocrine communication. Clin Ther. 2015;37(5):954-67.

    11. Indexed at, Google Scholar, Cross Ref

     

Get the App